Week 2 Flashcards
3 types of cancer treatment
radiation
surgery
chemotherapy
examples of precision medicine
targeted therapy
immunotherapy
Neoadjuvant (preoperatively) are used for what
administered prior to surgery to facilitate resection and prevent metastasis.
Adjuvant (postoperatively) are used for
after surgical debulking to kill micrometastases and reduce risk of distant relapse; increase disease-free survival.
examples of alkylating agents
Cisplatin, Carboplatin, Oxaliplatin, Busulfan, Chlorambucil, Dacarbarzine,
Mechlorethamine (Nitrogen Mustard), Mephalan, Nitroureas, Procarbazine, Temozolamid
examples of antimetabolites
Methotrexate, Fluorouracil, Mercaptopurine, Thioguanine, Cytarabin, Hydroxyurea,
Fludarabine, Leucovorin, Capecitabine, Gemcitabine, Aracytidine, Pemetrexed, Trimexrexate
examples of mitotic spindle agents
Docetaxel, Paclitaxel [Taxol], Vincristine, Vinblastine, Cabazitaxel, Eribulin.
topoisomerase inhibitors examples
Topo I inhibitors – Irinotecan, Topotecan; Topo II inhibitors – Etoposide, Teniposide
what do Antimetabolites do
limit the synthesis of nucleic acid precursors e.g. methotrexate inhibits dihydrofolate reductase, reducing the synthesis of folate which is necessary for purine and pyrimidine production. Similar agents – 5-fluorouracil, cytarabine.
what do Topoisomerase enzymes do
participate in the winding and unwinding of DNA and are inhibited by anthracyclines (doxorubicin, daunorubicin, epirubicin), epipodophyllotoxins (etoposide, teniposide) and camptothecins (irinotecan, topotecan).
PARAMETERS TO BE EVALUATED IN SYSTEMIC TREATMENTS response
Complete response (CR): disappearance of all target lesions. Partial response (PR): at least a 30% decrease in the sum of the longest diameter (LD) of targeted lesions. Stable disease (SD): neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD. Progressive disease (PD): at least a 20% increase in the sum of the LD of targeted lesions. Duration of response or time to progression (TTP): the time from response to progression.
PARAMETERS TO BE EVALUATED IN SYSTEMIC TREATMENTS SURVIVAL
Disease-free survival (DFS): from the time of treatment to first recurrence. Overall survival (OS): from the time of diagnosis to death.
what is mucositis and its symptoms and treatment
common complication of cancer chemotherapy
oral pain and burning
ulcerations
analgesia
how is P-glycoprotein (PGP) encoded by the MDR1 gene
multidrug resistance gene.
P-glycoprotein (PGP) mediates transport of certain drugs out of the cell thereby reducing their intracellular concentration and cytotoxicity.
PGP over-expression achieved increased expression of its mRNA with or without MDR1 gene amplification.
how can resistance be tackled
increasing the levels of platinum reaching tumours
tumour margin meaning
removing the rim of normal tissue surrounding the tumour
Drug resistance is effected by microenvironments give examples of what
fibroblasts
exosomes
vascualar abnormality
how is dna damaged included by ionizing radiation
doubled stranded base pair is damaged to stop replication leading to cell death
base and sugar damage, single-strand breaks,
double-strand breaks, and covalent intrastrand or interstrand crosslinking
what is the process of DNA
DNA damage is recognised by DNA damage sensor proteins,
(ii) transducer proteins then signal to effectors and (iii) this results in either cell cycle arrest, DNA repair or apoptosis